RFL - Rafael Holdings, Inc. Stock Price and Quote

RFL | Rafael Holdings, Inc. | [NYSE]

Real Estate | Real Estate Services | USA

Index	-	P/E	-	EPS (ttm)	-0.59	Insider Own	15.50%	Shs Outstand	23.16M	Perf Week	4.66%
Market Cap	48.88M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	18.72M	Perf Month	-3.81%
Income	-17.70M	PEG	-	EPS next Q	-	Inst Own	12.60%	Short Float / Ratio	0.42% / 1.27	Perf Quarter	-6.91%
Sales	0.30M	P/S	162.95	EPS this Y	-349.50%	Inst Trans	-43.83%	Short Interest	0.08M	Perf Half Y	3.06%
Book/sh	4.32	P/B	0.47	EPS next Y	-	ROA	-	Target Price	-	Perf Year	10.99%
Cash/sh	3.67	P/C	0.55	EPS next 5Y	-	ROE	-	52W Range	1.55 - 2.74	Perf YTD	8.02%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-120.90%	52W High	-26.28%	Beta	1.66
Dividend %	-	Quick Ratio	45.80	Sales past 5Y	-40.80%	Gross Margin	-	52W Low	30.32%	ATR	0.07
Employees	22	Current Ratio	45.80	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	60.18	Volatility	3.59% 3.42%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-45.20%	Profit Margin	-	Rel Volume	1.03	Prev Close	2.00
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	62.32K	Price	2.02
Recom	-	SMA20	4.39%	SMA50	7.25%	SMA200	2.37%	Volume	62,777	Change	1.00%

May-15-23 08:05AM	Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results (Business Wire)
May-02-23 08:12AM	Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL) (Business Wire)
Apr-04-23 08:00AM	Rafael Holdings Announces up to $5 Million Share Repurchase Program (GlobeNewswire) +17.68%
Mar-14-23 04:01PM	Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results (GlobeNewswire)
Dec-13-22 07:00AM	Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results (GlobeNewswire)
04:01PM	Loading…
Nov-15-22 04:01PM	Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities (GlobeNewswire) +6.52%
Oct-31-22 04:01PM	Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results (GlobeNewswire)
Sep-28-22 07:00AM	Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer (GlobeNewswire)
Aug-23-22 07:43AM	Rafael Holdings Sells its Building Located at 520 Broad Street in Newark, New Jersey and Associated 800-Car Public Garage (GlobeNewswire)
Aug-03-22 08:00AM	Cornerstone Pharmaceuticals Announces Successful Completion of Phase 1b Clinical Trial for CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer (GlobeNewswire)
Jul-10-22 08:08AM	Howard Jonas Is The Founder & Chairman of Rafael Holdings, Inc. (NYSE:RFL) And They Just Picked Up 83% More Shares (Simply Wall St.)
Jul-06-22 08:00AM	Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D. (GlobeNewswire) -5.88%
Jun-27-22 08:00AM	Cornerstone Pharmaceuticals to Present Pancreatic Cancer Data on CPI-613® (Devimistat) From Its Open-Label Phase 1 Study at the European Society of Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2022 (GlobeNewswire)
Jun-16-22 02:14PM	Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism UPDATE (GlobeNewswire)
08:00AM	Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism (GlobeNewswire)
04:01PM	Loading…
Jun-14-22 04:01PM	Rafael Holdings Reports Third Quarter Fiscal 2022 Financial Results (GlobeNewswire)
Jun-01-22 08:00AM	Cornerstone Pharmaceuticals to Present Pancreatic Cancer, Clear Cell Sarcoma and Biliary Tract Cancer Research Featuring CPI-613® (Devimistat) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (GlobeNewswire)
May-24-22 11:04AM	European Medicines Agency Grants Orphan Drug Designation to Cornerstone Pharmaceuticals CPI-613® (Devimistat) for Treatment of Patients with Advanced Unresectable Biliary Tract Cancer (GlobeNewswire)
May-19-22 09:00AM	Rafael Pharmaceuticals, Inc. Announces Corporate Name Change to Cornerstone Pharmaceuticals, Inc. (GlobeNewswire)
Mar-17-22 04:01PM	Rafael Holdings Reports Second Quarter Fiscal 2022 Financial Results (GlobeNewswire)
Feb-17-22 12:32PM	Rafael Holdings, Inc. (NYSE:RFL) insider upped their holding by 4.1% earlier this year (Simply Wall St.) -8.61%
Jan-24-22 01:38PM	SkyOak Wealth, LLC Buys iShares Russell 2000 Growth ETF, Vanguard S&P 500 ETF, Vanguard ... (GuruFocus.com)
Jan-21-22 07:00AM	William Bill Conkling to assume the role of Chief Executive Officer as of February 1, 2022 (GlobeNewswire)
Jan-19-22 09:38AM	Adirondack Retirement Specialists, Inc. Buys IDT Corp, Camping World Holdings Inc, Semler ... (GuruFocus.com)
Jan-18-22 08:30AM	Rafael Pharmaceuticals Announces Ongoing Successful Enrollment and Opening of Additional Sites for Phase 2 Clinical Trial of CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer (GlobeNewswire) -8.05%
Jan-06-22 08:30AM	Rafael Pharmaceuticals Announces Successful Completion of Dose Escalation with No Dose-Limiting Toxicity (DLT) in First Cohort of APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma (GlobeNewswire)
Dec-17-21 09:40AM	Is Rafael Holdings (NYSE:RFL) Using Too Much Debt? (Simply Wall St.)
Dec-15-21 04:30PM	Rafael Holdings Reports First Quarter Fiscal 2022 Financial and Operating Results (GlobeNewswire)
Dec-13-21 08:00AM	Rafael Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) From Phase 2 Clinical Trial for Refractory Burkitt Lymphoma at the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition (GlobeNewswire)
Nov-22-21 07:00AM	Rafael Holdings Realigns Leadership Team to Support Earlier Stage Pipeline Focus (GlobeNewswire) -7.41%
09:00AM	Loading…
Nov-11-21 09:00AM	Rafael Pharmaceuticals Announces First Patient Enrolled in APOLLO 613 Phase 1/2 Clinical Trial of CPI-613® (Devimistat) in Patients with Relapsed Clear Cell Sarcoma (GlobeNewswire)
Nov-03-21 09:00AM	European Medicines Agency Grants Orphan Drug Designation to Rafael Pharmaceuticals CPI-613® (Devimistat) for Treatment of Patients with Relapsed or Refractory Burkitt's Lymphoma (GlobeNewswire) +5.26%
Oct-29-21 11:00AM	Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Rafael Holdings, Inc. (RFL) Investigation (ACCESSWIRE) -6.55%
Oct-28-21 08:00AM	Rafael Pharmaceuticals Provides Update on Pivotal Phase 3 Clinical Trial in Patients with Metastatic Pancreatic Cancer and Interim Analysis of Pivotal Phase 3 Clinical Trial in Patients with Relapsed or Refractory Acute Myeloid Leukemia (GlobeNewswire) -73.19%
07:00AM	Rafael Holdings Provides Update on Rafael Pharmaceuticals Two Phase 3 Trials of CPI-613® (Devimistat), AVENGER 500 in Metastatic Pancreatic Cancer and ARMADA 2000 in Relapsed or Refractory Acute Myeloid Leukemia (GlobeNewswire)
Oct-25-21 03:05PM	Investing in Rafael Holdings (NYSE:RFL) three years ago would have delivered you a 271% gain (Simply Wall St.)
Oct-20-21 02:17AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates GTS, RFL, ACBI, HOMB; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Oct-18-21 05:41PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of Rafael Holdings, Inc. with Rafael Pharmaceuticals, Inc. (Newsfile)
05:30PM	Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 (GlobeNewswire)
04:30PM	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2021 Financial and Operating Results and Provides Business Update (GlobeNewswire)
Oct-13-21 03:32PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COLB, ESXB, RFL, CLDB, VICI; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Oct-12-21 01:45PM	MERGER ALERT - INOV, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Oct-06-21 06:30AM	Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical Officer (PR Newswire) +6.09%
Sep-27-21 08:00AM	Rafael Pharmaceuticals Announces APOLLO613 Phase I/II Clinical Trial of CPI-613® (devimistat) in Combination with Hydroxychloroquine in Patients with Relapsed Clear Cell Sarcoma Begins Enrollment at City of Hope in Duarte, Calif. (GlobeNewswire)
Sep-24-21 04:30PM	Rafael Holdings Continues to Expand its Management Team with a Highly Experienced Global Biopharmaceutical Executive to Build a Fully Integrated Cancer Metabolism Therapeutics Company and Announces Inducement Grant Under NYSE Rule 303A.08 (PR Newswire) -6.25%
Sep-17-21 04:01PM	Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 (PR Newswire)
Sep-14-21 08:27AM	Rafael Holdings Appoints Patrick Fabbio as Chief Financial Officer (PR Newswire)
Sep-11-21 04:55PM	INVESTIGATION: Halper Sadeh LLP Investigates GTS, RFL, NLOK, MDLA, STMP, GPX; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Sep-09-21 05:45PM	MERGER ALERT INOV, GNOG, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Sep-04-21 11:47AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HRC, RAVN, RFL, STMP; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Sep-02-21 12:30PM	MERGER ALERT - GNOG, and RFL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Sep-01-21 11:55AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, SAFM, SNR; Shareholders are Encouraged to Contact the Firm (ACCESSWIRE)
Aug-30-21 04:30PM	NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Rafael Holdings, Inc. (NYSE:RFL), American National Group, Inc. (NASDAQ:ANAT), Veoneer, Inc. (NYSE:VNE) (ACCESSWIRE) -8.82%
10:14AM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, CSOD, VICI, SIC; Shareholders are Encouraged to Contact the Firm (GlobeNewswire)
Aug-27-21 11:45AM	MERGER ALERT - GNOG, RFL, and SC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies (ACCESSWIRE)
Aug-26-21 05:10PM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE:RFL) (ACCESSWIRE) +9.19%
04:25PM	INVESTIGATION: Halper Sadeh LLP Investigates RFL, FIVN, MDLA, CMO, SNR; Shareholders are Encouraged to Contact the Firm (PR Newswire)
01:24PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Rafael Holdings, Inc. with Rafael Pharmaceuticals, Inc. (Newsfile)
11:51AM	One Rafael Holdings, Inc. (NYSE:RFL) insider upped their stake by 2,030% in the previous year (Simply Wall St.)
11:20AM	Kaskela Law LLC Announces Investigation of Rafael Holdings, Inc. on Behalf of Stockholders - RFL (ACCESSWIRE)
08:00AM	President and CEO of Rafael Pharmaceuticals, Sanjeev Luther, to Present at the 11th Annual World Orphan Drug Congress USA 2021 (GlobeNewswire)
Aug-25-21 10:00AM	Rafael Pharmaceuticals Announces the Successful Completion of Phase 1b Clinical Trial and Initiates Phase 2 for CPI-613® (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer (GlobeNewswire) +18.49%
Aug-24-21 04:01PM	Rafael Holdings Announces Closing of $104.2 Million Private Placement (PR Newswire) -6.74%
11:30AM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE - RFL) (ACCESSWIRE)
Aug-20-21 07:00AM	Rafael Holdings Announces $104.2 Million Private Placement (PR Newswire) -13.15%
Aug-19-21 04:17PM	ALERT: Halper Sadeh LLP Investigates ALTA, TGRF, RFL, HFC, MNR; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Aug-18-21 11:56AM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of RIVE, IACB, BCYP, and RFL Mergers (GlobeNewswire)
Aug-17-21 10:11AM	Rafael Holdings Expands Leadership Team with Three Highly Experienced Global Biopharmaceutical Executives to Build a Fully Integrated Cancer Metabolism Therapeutics Company (PR Newswire)
Aug-16-21 08:17AM	INVESTIGATION: Halper Sadeh LLP Investigates ALTA, TGRF, RFL, CLDB; Shareholders are Encouraged to Contact the Firm (GlobeNewswire)
08:01AM	RAFAEL (RFL) STOCKHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Rafael Holdings, Inc. (Business Wire)
12:00AM	SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Rafael Holdings, Inc. (RFL) and Encourages Stockholders to Contact the Firm (GlobeNewswire)
Aug-12-21 08:29PM	NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Rafael Holdings, Inc. (NYSE:RFL), American National Group, Inc. (NASDAQ:ANAT), Intersect ENT, Inc. (NASDAQ:XENT) (ACCESSWIRE)
Aug-11-21 09:00AM	INVESTIGATION: Halper Sadeh LLP Investigates ALTA, TGRF, FFWM, RFL, CLDB; Shareholders are Encouraged to Contact the Firm (PR Newswire) -6.68%
Aug-10-21 07:09PM	NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Golden Nugget Online Gaming, Inc. (NASDAQ:GNOG), Intersect ENT, Inc. (NASDAQ:XENT), Rafael Holdings, Inc. (NYSE:RFL) (ACCESSWIRE)
Aug-09-21 05:57PM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE:RFL) (ACCESSWIRE)
09:00AM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, RFL, LONE, ONEM; Shareholders are Encouraged to Contact the Firm (ACCESSWIRE)
Aug-05-21 07:03PM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE - RFL) (ACCESSWIRE) +5.27%
10:39AM	Moore Kuehn Encourages LONE, MACQ, RFL, and MDLA Investors to Contact Law Firm (GlobeNewswire)
Aug-04-21 07:53PM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE:RFL) (ACCESSWIRE)
Aug-03-21 07:48PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RBNC, GPX, RFL, IKNX; Shareholders are Encouraged to Contact the Firm (PR Newswire)
11:11AM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE - RFL) (ACCESSWIRE)
Aug-02-21 02:00PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, LDL, MMAC, IKNX; Shareholders are Encouraged to Contact the Firm (ACCESSWIRE)
Jul-29-21 04:47PM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE - RFL) (ACCESSWIRE)
11:47AM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates RFL, VNE, ACBI, KIN; Shareholders are Encouraged to Contact the Firm (GlobeNewswire)
Jul-27-21 06:46PM	SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Rafael Holdings, Inc. (NYSE:RFL) (ACCESSWIRE)
06:03PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, FCCY, RBNC, GPX; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Jul-26-21 08:01AM	RAFAEL (RFL) INVESTIGATION NOTICE - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Rafael Holdings, Inc. (GlobeNewswire)
Jul-08-21 12:13PM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates SBBP, RFL, CLDB, MPB; Shareholders are Encouraged to Contact the Firm (GlobeNewswire)
09:30AM	RFL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Rafael Holdings, Inc. (RFL) and Encourages Shareholders to Contact the Firm (GlobeNewswire)
Jul-03-21 07:49PM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates RFL, SHSP, ICBK, CLDB; Shareholders are Encouraged to Contact the Firm (PR Newswire)
Jul-01-21 02:00PM	INVESTOR ALERT: Kaskela Law LLC Announces Stockholder Investigation of Rafael Holdings, Inc. - RFL (ACCESSWIRE) +6.37%
08:00AM	Rafael Pharmaceuticals Announces Positive Preplanned Interim Futility Analysis of Pivotal Phase 3 Trial (ARMADA 2000) of CPI-613® (Devimistat) for Relapsed or Refractory Acute Myeloid Leukemia (AML) (GlobeNewswire)
Jun-30-21 08:00AM	Rafael Pharmaceuticals to Present Pancreatic & Biliary Tract Cancer Data on CPI-613® (Devimistat) from its Multicenter, Randomized Phase 1b/2 Trials at the 2021 European Society of Medical Oncology World Gastrointestinal (GI) Congress (GlobeNewswire)
Jun-29-21 11:00AM	FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (Devimistat) for Treatment of Biliary Cancer (GlobeNewswire)
09:00AM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates SYKE, RFL, SHSP, ICBK; Shareholders are Encouraged to Contact the Firm (GlobeNewswire)
Jun-28-21 02:00PM	STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Rafael Holdings, Inc. and Encourages Stockholders to Contact the Firm - RFL (Newsfile)
Jun-25-21 10:08PM	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Rafael Holdings, Inc. - RFL (PR Newswire)
03:17PM	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Rafael Holdings, Inc. Merger (GlobeNewswire)
Jun-24-21 12:18PM	RAFAEL HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Rafael Holdings, Inc. - RFL (Business Wire)
12:12PM	INVESTIGATION ALERT: Halper Sadeh LLP Investigates XEC, RFL, ICBK, CLDR; Shareholders are Encouraged to Contact the Firm (PR Newswire)

Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), that is in Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JONAS HOWARD S	Executive Chairman	Jul 06	Buy	1.86	3,225,806	5,999,999	3,338,367	Jul 07 03:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience